Selective cell cycle arrest and induction of apoptosis in human prostate cancer cells by a polyphenol-rich extract of Solanum nigrum

International Journal of Molecular Medicine

Volumn 29, Issue 2, 2012, Pages 277-284

  Akbar, Nawab ^a,b,d   Thakur, Vijay S ^a,b   Yunus, Mohammad ^d   Mahdi, Abbas Ali ^e   Gupta, Sanjay ^a,b,c  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

^d BABASAHEB BHIMRAO AMBEDKAR UNIVERSITY   (India)

^e KING GEORGE'S MEDICAL UNIVERSITY   (India)

Author keywords

Apoptosis; Cell proliferation; Chemotherapy; DNA fragmentation; Prostate cancer

Indexed keywords

POLYPHENOL DERIVATIVE; SOLANUM NIGRUM EXTRACT;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL LINE; CELL PROLIFERATION; CELL STRAIN LNCAP; CELL VIABILITY; CYTOTOXICITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; SOLANUM NIGRUM; WART VIRUS;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; HUMANS; MALE; PLANT EXTRACTS; POLYPHENOLS; PROSTATIC NEOPLASMS; SOLANUM NIGRUM;

EID: 84855171279     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2011.835     Document Type: Article

References (36)

1. Petrelli A and Giordano S: From single- to multi-target drugs in cancer therapy: when aspecificity becomes an advantage. Curr Med Chem 15: 422-432, 2008. (Pubitemid 351472408)
2. Schwartz GK and Shah MA: Targeting the cell cycle: a new approach to cancer therapy. J Clin Oncol 23: 9408-9421, 2005.
3. Jemal A, Siegel R, Xu J and Ward E: Cancer statistics, 2010. CA Cancer J Clin 60: 277-300, 2010.
4. Wegiel B, Evans S, Hellsten R, Otterbein LE, Bjartell A and Persson JL: Molecular pathways in the progression of hormone-independent and metastatic prostate cancer. Curr Cancer Drug Targets 10: 392-401, 2010.
5. Neergheen VS, Bahorun T, Taylor EW, Jen LS and Aruoma OI: Targeting specific cell signaling transduction pathways by dietary and medicinal phytochemicals in cancer chemoprevention. Toxicology 278: 229-241, 2010.
6. Jain R, Sharma A, Gupta S, Sarethy IP and Gabrani R: Solanum nigrum: current perspectives on therapeutic properties. Altern Med Rev 16: 78-85, 2011.
7. Raju K, Anbuganapathi G, Gokulakrishnan V, Rajkapoor B, Jayakar B and Manian S: Effect of dried fruits of Solanum nigrum LINN against CCl4-induced hepatic damage in rats. Biol Pharm Bull 26: 1618-1619, 2003. (Pubitemid 41699647)
8. Zakaria ZA, Sulaiman MR, Morsid NA, Aris A, Zainal H, Pojan NH and Kumar GH: Antinociceptive, anti-inflammatory and antipyretic effects of Solanum nigrum aqueous extract in animal models. Methods Find Exp Clin Pharmacol 31: 81-88, 2009.
9. Prashanth Kumar V, Shashidhara S, Kumar MM and Sridhara BY: Cytoprotective role of Solanum nigrum against gentamicin-induced kidney cell (Vero cells) damage in vitro. Fitoterapia 72: 481-486, 2001. (Pubitemid 32594797)
10. Jeong JB, De Lumen BO and Jeong HJ: Lunasin peptide purified from Solanum nigrum L. protects DNA from oxidative damage by suppressing the generation of hydroxyl radical via blocking fenton reaction. Cancer Lett 293: 58-64, 2010.
11. Son YO, Kim J, Lim JC, Chung Y, Chung GH and Lee JC: Ripe fruit of Solanum nigrum L. inhibits cell growth and induces apoptosis in MCF-7 cells. Food Chem Toxicol 41: 1421-1428, 2003. (Pubitemid 37289192)
12. Heo KS and Lim KT: Glycoprotein isolated from Solanum nigrum L. modulates the apoptotic-related signals in 12-O-tetradecanoylphorbol 13-acetate- stimulated MCF-7 cells. J Med Food 8: 69-77, 2005.
13. Hsu JD, Kao SH, Tu CC, Li YJ and Wang CJ: Solanum nigrum L. extract inhibits 2-acetylaminofluorene-induced hepatocarcinogenesis through overexpression of glutathione S-transferase and antioxidant enzymes. J Agric Food Chem 57: 8628-8634, 2009.
14. Lin HM, Tseng HC, Wang CJ, Chyau CC, Liao KK, Peng PL and Chou FP: Induction of autophagy and apoptosis by the extract of Solanum nigrum Linn in HepG2 cells. J Agric Food Chem 55: 3620-3628, 2007.
15. Bonitati J, Elliott WB and Miles PG: Interference by carbohydrate and other substances in the estimation of protein with the Folin-Ciocalteu reagent. Anal Biochem 31: 399-404, 1969.
16. Srivastava JK and Gupta S: Antiproliferative and apoptotic effects of chamomile extract in various human cancer cells. J Agric Food Chem 55: 9470-9478, 2007. (Pubitemid 350205299)
17. Wang HC, Chung PJ, Wu CH, Lan KP, Yang MY and Wang CJ: Solanum nigrum L. polyphenolic extract inhibits hepatocarcinoma cell growth by inducing G2/M phase arrest and apoptosis. J Sci Food Agric 91: 178-185, 2011.
18. Wang ZY, Wang DM, Loo TY, et al: Spatholobus suberectus inhibits cancer cell growth by inducing apoptosis and arresting cell cycle at G2/M checkpoint. J Ethnopharmacol 133: 751-758, 2011.
19. Dawood S and Leyland-Jones B: Pharmacology and pharmacogenetics of chemotherapeutic agents. Cancer Invest 27: 482-488, 2009.
20. Lin Y, Bai L, Chen W and Xu S: The NF-kappaB activation pathways, emerging molecular targets for cancer prevention and therapy. Expert Opin Ther Targets 14: 45-55, 2010.
21. Freemantle SJ, Liu X, Feng Q, et al: Cyclin degradation for cancer therapy and chemoprevention. J Cell Biochem 102: 869-877, 2007. (Pubitemid 350036927)
22. Häcker G: The morphology of apoptosis. Cell Tissue Res 301: 5-17, 2000.
23. Katsman A, Umezawa K and Bonavida B: Chemosensitization and immunosensitization of resistant cancer cells to apoptosis and inhibition of metastasis by the specific NF-kappaB inhibitor DHMEQ. Curr Pharm Des 15: 792-808, 2009.
24. Kögel D, Fulda S and Mittelbronn M: Therapeutic exploitation of apoptosis and autophagy for glioblastoma. Anticancer Agents Med Chem 10: 438-449, 2010.
25. Adhami VM, Aziz MH, Reagan-Shaw SR, Nihal M, Mukhtar H and Ahmad N: Sanguinarine causes cell cycle blockade and apoptosis of human prostate carcinoma cells via modulation of cyclin kinase inhibitor-cyclin-cyclin- dependent kinase machinery. Mol Cancer Ther 3: 933-940, 2004. (Pubitemid 39199588)
26. Ikeda T, Tsumagari H and Nohara T: Steroidal oligoglycosides from Solanum nigrum. Chem Pharm Bull (Tokyo) 48: 1062-1064, 2000. (Pubitemid 30485408)
27. Zhou X, He X, Wang G, Gao H, Zhou G, Ye W and Yao X: Steroidal saponins from Solanum nigrum. J Nat Prod 69: 1158-1163, 2006. (Pubitemid 44409787)
28. Yang MY, Hsu LS, Peng CH, Shi YS, Wu CH and Wang CJ: Polyphenol-rich extracts from Solanum nigrum attenuated PKC alpha-mediated migration and invasion of hepatocellular carcinoma cells. J Agric Food Chem 58: 5806-5814, 2010.
29. Arulmozhi V, Krishnaveni M, Karthishwaran K, Dhamodharan G and Mirunalini S: Antioxidant and antihyperlipidemic effect of Solanum nigrum fruit extract on the experimental model against chronic ethanol toxicity. Pharmacogn Mag 6: 42-50, 2010.
30. Wang HC, Wu DH, Chang YC, Li YJ and Wang CJ: Solanum nigrum Linn water extract inhibits metastasis in mouse melanoma cells in vitro and in vivo. J Agric Food Chem 58: 11913-11923, 2010.
31. Li J, Li Q, Peng Y, Zhao R, Han Z and Gao D: Protective effects of fraction 1a of polysaccharides isolated from Solanum nigrum Linn on thymus in tumor-bearing mice. J Ethnopharmacol 129: 350-356, 2010.
32. Huang HC, Syu KY and Lin JK: Chemical composition of Solanum nigrum Linn extract and induction of autophagy by leaf water extract and its major flavonoids in AU565 breast cancer cells. J Agric Food Chem 58: 8699-8708, 2010.
33. Lee SJ, Oh PS, Ko JH, Lim K and Lim KT: A 150-kDa glycoprotein isolated from Solanum nigrum L. has cytotoxic and apoptotic effects by inhibiting the effects of protein kinase C alpha, nuclear factor-kappa B and inducible nitric oxide in HCT-116 cells. Cancer Chemother Pharmacol 54: 562-572, 2004. (Pubitemid 40022253)
34. Heo KS, Lee SJ, Ko JH, Lim K and Lim KT: Glycoprotein isolated from Solanum nigrum L. inhibits the DNA-binding activities of NF-kappaB and AP-1, and increases the production of nitric oxide in TPA-stimulated MCF-7 cells. Toxicol In Vitro 18: 755-763, 2004. (Pubitemid 39311886)
35. Oh PS and Lim KT: HeLa cells treated with phytoglycoprotein (150 kDa) were killed by activation of caspase 3 via inhibitory activities of NF-kappaB and AP-1. J Biomed Sci 14: 223-232, 2007.
36. Lee SJ and Lim KT: Cell death signal by glycine- and proline-rich plant glycoprotein is transferred from cytochrome c and nuclear factor kappa B to caspase 3 in Hep3B cells. J Nutr Biochem 19: 166-174, 2008.